ABBV

MKT CAP:$376B

AbbVie Inc

Market Cap

$376B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NYSE

Healthcare·Drug Mfg.·🇺🇸·NYSE

Stock Price

$223.02-$2.59 (-1.15%)

Jun 8, 2026

52W High $238.7152W Low $176.56

Company Details

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq...

CEO

—

IPO Date

Jan 2, 2013

Website

www.abbvie.com

Key Metrics TTM

Revenue

$62.8B

+9.5% YoY

Net Income

$3.6B

EPS (Diluted)

Free Cash Flow

$20.9B

Revenue / Share

$35.41

Gross Margin

70.7%

Operating Margin

27.6%

Net Margin

5.8%

FCF Margin

33.2%

P/S

6.0x

P/E

103.4x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

May 8, 2026

$15.0B+12.4%

FY 2025

Feb 20, 2026

$61.2B+8.6%

Q4 2025

Feb 20, 2026

$16.6B+10.0%

Q3 2025

Nov 4, 2025

$15.8B+9.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee